Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
RenovoRx Inc
NASDAQ:RNXT
|
US |
|
Hengxin Shambala Culture Co Ltd
SZSE:300081
|
CN |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (27.1), the stock would be worth kr-0.35 (513% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -6.6 | kr0.09 |
0%
|
| Industry Average | 27.1 | kr-0.35 |
-513%
|
| Country Average | 13.6 | kr-0.18 |
-307%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
kr111.7m
|
/ |
Jan 2026
kr-17.2m
|
= |
|
|
kr111.7m
|
/ |
Dec 2026
kr1.8m
|
= |
|
|
kr111.7m
|
/ |
Dec 2027
kr-23.4m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| DK |
|
Pharma Equity Group A/S
CSE:PEG
|
105.3m DKK | -6.6 | -4.1 | |
| DE |
|
Vonovia SE
XETRA:VNA
|
19.9B EUR | 26.7 | 5.4 | |
| IL |
|
Azrieli Group Ltd
TASE:AZRG
|
55.8B ILS | 36.5 | 29.5 | |
| HK |
S
|
Swire Properties Ltd
HKEX:1972
|
144.1B HKD | 22.1 | -94 | |
| BM |
|
Hongkong Land Holdings Ltd
SGX:H78
|
17.2B USD | 66.2 | 13.7 | |
| CH |
|
Swiss Prime Site AG
SIX:SPSN
|
10.9B CHF | 39 | 28.9 | |
| CN |
|
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
|
109.6B HKD | 17.5 | 24.1 | |
| CL |
P
|
Plaza SA
SGO:MALLPLAZA
|
10T CLP | 21.4 | 7 | |
| SG |
|
Capitaland Investment Ltd
SGX:9CI
|
14.3B SGD | 35.1 | 98.4 | |
| CN |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
67.8B CNY | 13 | 16.1 | |
| SE |
S
|
Sagax AB
STO:SAGA A
|
88.8B SEK | 28.7 | 21.8 |
Market Distribution
| Min | 0.8 |
| 30th Percentile | 6.6 |
| Median | 13.6 |
| 70th Percentile | 19.5 |
| Max | 473.6 |
Other Multiples
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
